Clinical Trials on Chronic Obstructive Pulmonary Disease in South Africa
Total 2657 results
-
Nuvaira, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)Netherlands, South Africa
-
MedImmune LLCCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease, COPDFrance, Poland, South Africa, Spain, United States, Canada, United Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)Spain, Germany, South Africa, Australia, Poland, New Zealand, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Chile, South Africa, New Zealand
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveSouth Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDAustria, France, Hungary, Italy, Poland, Portugal, Russian Federation, South Africa, Spain, Canada, United Kingdom, Australia, Netherlands, Switzerland
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Mundipharma Research LimitedCompletedChronic Obstructive Pulmonary DiseaseUkraine, United Kingdom, Spain, Bulgaria, South Africa, Russian Federation, Germany, Hungary, Lithuania, Slovakia, Macedonia, The Former Yugoslav Republic of, Latvia, Romania, Korea, Republic of, Poland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Nephron Pharmaceuticals CorporationRho, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
The George InstituteNational Health and Medical Research Council, AustraliaCompletedChronic Obstructive Pulmonary DiseaseAustralia
-
Mylan Inc.Theravance BiopharmaCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, Germany
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Monash UniversityUniversity of Melbourne; La Trobe University; Institute for Breathing and Sleep... and other collaboratorsRecruitingChronic Obstructive Pulmonary DiseaseAustralia
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, New Zealand
-
PfizerCompletedChronic Obstructive Pulmonary DiseaseAustralia, Netherlands, Canada, Korea, Republic of, Argentina, Hungary, South Africa, France, Russian Federation, Chile, Czechia, Greece, United Kingdom
-
Alexza Pharmaceuticals, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Endo PharmaceuticalsAlkermes, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Macquarie University, AustraliaCompletedChronic Obstructive Pulmonary Disease (COPD)Australia
-
Sheffield Teaching Hospitals NHS Foundation TrustNovartisCompleted
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaQuintiles, Inc.Completed
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Germany, Poland, Romania, South Africa
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, France, Poland, South Africa, Canada, Germany
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)United States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Czech Republic, France, Hungary, Italy, Peru, Poland, Russian Federation, South Africa, Spain, Ukraine
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany
-
Alkermes, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
SunovionCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseRomania, Lithuania, Canada, France, Hungary, India, South Africa, Korea, Republic of, Latvia, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Colombia, Argentina, Germany, Spain, Turkey, Guatemala, Mexico, Australia, Denmark, South Africa, Philippines
-
US Department of Veterans AffairsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, United States, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD) | Chronic BronchitisUnited States, Canada, Denmark, Spain, United Kingdom, Taiwan, New Zealand, Australia, Germany, Israel, South Africa, Czechia, Hungary, Poland, Netherlands
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, New Zealand
-
NovartisCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Spain, Turkey, France, Netherlands, Germany
-
Novartis PharmaceuticalsCompletedCOPDSpain, Germany, Belgium, Poland, South Africa, Australia, Greece, Israel, Sweden, Hong Kong, Thailand, Bulgaria, Singapore, Denmark, Finland, Hungary, Romania, Malaysia
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Canada, Denmark, Germany, South Africa, Spain, United Kingdom, Italy, Argentina, Bulgaria, Mexico, Turkey, Poland, Netherlands